共 40 条
[1]
Balch CM(2001)Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system J Clin Oncol 19 3622-3634
[2]
Soong SJ(1994)Cutaneous melanoma: current practice and surgical controversies Curr Probl Surg 31 253-374
[3]
Gershenwald JE(1999)Prognosis of thick cutaneous melanoma J Am Coll Surg 188 241-247
[4]
Mansfield PF(2000)Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma Ann Surg Oncol 7 160-165
[5]
Lee JE(2001)Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence Ann Surg 233 250-258
[6]
Balch CM(1997)The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Onco 24 S8-10
[7]
Kim SH(1997)Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 21 788-92;
[8]
Garcia C(2000)Surgical management of malignant melanoma using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy: the Emory experience Am Surg 66 763-767
[9]
Rodriguez J(1990)Prognosis of thick cutaneous melanoma of the trunk and extremity Arch Surg 125 322-326
[10]
Gershenwald JE(1998)Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma Ann Surg Oncol 5 322-328